ODDB.org: Open Drug Database

Neuraxpharm Switzerland AG - Briumvi 25 mg/ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	69599	Sequence	01
Product name	Briumvi 25 mg/ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L04AG14	ATC-Description
Introduction of Sequence	06.02.2025

Composition

ublituximabum 150 mg, natrii chloridum, natrii citras dihydricus, polysorbatum 80, acidum hydrochloridum concentratum, aqua ad iniectabile ad solutionem pro 6 ml corresp. natrium 31.57 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Ublituximabum	150mg / 6ml

BAG: Active Agent	Dose
Ublituximabum	150 mg

Inactive agents
Acidum Hydrochloridum Concentratum
Sodium Chloride
Natrii Citras Dihydricus
Polysorbatum 80

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		2134.91	2338.25	A	SL	No
002	3	6404.74	6879.05	A	SL	No

2025	©ywesee GmbH